Search Results

You are looking at 1 - 10 of 160 items for :

  • "hepatitis C virus" x
  • Refine by Access: All Content x
Clear All
Orvosi Hetilap
Authors:
Marianna Lakatos
,
Krisztina Hagymási
, and
Gabriella Lengyel

Kahn, M., Jahan, S., Khaliq, S. és mtsai: Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. Arch. Virol., 2010, 155 , 1735

Open access
Hungarian Medical Journal
Authors:
Gabriella Lengyel
,
Zsuzsa Aszalós
, and
Zsolt Tulassay

Roy, K., Hay, G., Andragetti, R. et al.: Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol. Infect., 2002, 129 , 577

Restricted access

mtsai: Report on the first trial with the HCV antibody test in Hungary. First Int. Meeting on Hepatitis C Virus, Rome, Sept. 14–15. 1989. Pár, A.: Antibody to hepatitis C virus in Hungary. Lancet

Restricted access

207 Watanabe, Y., Harada, S., Saito, I. és mtsai: Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma. Int. J. Cancer

Open access

–361. 2 Pár, G., Berki, T., Pálinkás, L., et al.: Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment. [A hepatitis C vírus

Restricted access
Orvosi Hetilap
Authors:
Anita Netyő
,
Gabriella Lengyel
, and
János Fehér

36 Alter, M. J.: Epidemiology of hepatitis C virus infection. World J. Gastroenterol., 2007, 13 , 2436–2441. Alter M. J

Restricted access

Bartenschlager, R., Cosset, F. L., Lohmann, V.: Hepatitis C virus replication cycle. J. Hepatol., 2010, 53 (3), 583–585. 4 Vermehren, J., Sarrazin, C.: New HCV therapies on

Restricted access
Orvosi Hetilap
Authors:
Fanni Gelley
,
György Gámán
,
Zsuzsanna Gerlei
,
Gergely Zádori
,
Dénes Görög
,
László Kóbori
,
Imre Fehérvári
,
János Schuller
,
László Szőnyi
,
Péter Nagy
,
Attila Doros
,
János Fazakas
,
Gabriella Lengyel
,
Zsuzsa Schaff
,
András Kiss
,
Enikő Sárváry
, and
Balázs Nemes

. T., et al.: A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transpl., 2007, 13 , 975–983. Stravitz R. T

Open access

2483 Pawlotsky, J. M., Chevaliez, S., McHutchison, J. G.: The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology, 2007, 132 , 1979

Restricted access

results associated with the management of hepatitis C virus-induced diseases in Italy. Clinicoecon. Outcomes Res., 2014, 6, 303–310. 7 Vietri, J., Prajapati, G

Restricted access